Olympus Pays Record Anti-Kickback Penalty For Device Case
This article was originally published in The Gray Sheet
The endoscope-maker resolved a federal investigation into kickbacks with a $600-million-plus payment, as well as a deferred prosecution agreement and a corporate integrity agreement that come with serious commitments to improving compliance.
You may also be interested in...
The $350m settlement resolves False Claims Act allegations Shire and its subsidiaries used tactics including lavish meals, free medical equipment, unearned speaker payments and cash to encourage doctors to prescribe the company’s Dermagraft human skin substitute.
Representatives from both parties questioned US federal officials and a contractor as to what could be done to more efficiently stop fraud.
Signing a deal worth up to $1.5bn, Teva is hoping Sanofi’s dominance in immunology via the mega-blockbuster Dupixent can help it compete with frontrunners Pfizer/Roivant and Merck & Co in a new anti-inflammatory space.